Scientists at the Groote Schuur Hospital in Cape Town have started a new trial to investigate the potential to repurpose an anti-diarrhea drug, Nitazoxanid, in order to treat COVID-19.
This low cost drug is one of several that scientists are hoping to repurpose in order to fight the virus.
Pulmonologists at Groote Schuur say that the anti-diarrheal agent has shown to be deadly to SARS-COVID 2, which is what causes COVID-19. Over 900 participants have been enrolled in the trial and it will be running in various places countrywide.
To tell us more were now joined by Professor Keertan Dheda, who is the head of Pulmonology at the University of Cape Town and Groote Schuur.
For more news, visit sabcnews.com and also #SABCNews, #Coronavirus, #COVID19, #COVID-19News on Social Media.
